Research Alliance Corporation III: 5%+ holders

Key facts

• Filed 2026-09-11 · Holder: Great Point Partners, LLC · Percent: 6.49% · SCHEDULE 13G
• Filed 2026-08-14 · Holder: ADAR1 Capital Management, LLC · Percent: 8.4% · SCHEDULE 13G
• Filed 2026-08-14 · Holder: Balyasny Asset Management L.P. · Percent: 6.43% · SCHEDULE 13G
• Filed 2026-08-14 · Holder: TCG Crossover GP III, LLC · Percent: 6.4% · SCHEDULE 13G
• Filed 2026-08-13 · Holder: Spruce Street Capital LP · Percent: 6.4% · SCHEDULE 13G

Research Alliance Corporation III has 12 Schedule 13D or 13G filings on record since 2026-05-28. 11 holders' latest filing reports 5% or more of class a ordinary shares, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Research Alliance Corporation III and the warning signs.

See Research Alliance Corporation III's free Snapshot Watch Research Alliance Corporation III: email me the next time it files something

Free to see. No signup.

Want the whole picture on Research Alliance Corporation III?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Research Alliance Corporation III: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Research Alliance Corporation III covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   12 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Purpose of Transaction (Item 4)

Research Alliance Holdings III LLC

Item 4 of the Statement is hereby amended and supplemented as follows: Business Combination Agreement On July 26, 2026, the Issuer, OHB Pediatrics Ltd., a company incorporated under the laws of England and Wales (the "Company"), and the shareholders of the Company (the "Shareholders"), entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the "Business Combination Agreement"), pursuant to which, among other things and subject to the terms and conditions contained therein, the Issuer will acquire 100% of the outstanding shares in the capital of the Company from the Shareholders in exchange for newly issued shares of the RACC Common Stock (as defined below) (the "Share Acquisition"). The transactions contemplated by the Business Combination Agreement are referred to herein as the "Transactions." The Business Combination Agreement and the Transactions were unanimously approved by the boards of directors of each of the Issuer and the Company. The Transactions are expected to close in the second half of 2026, following the receipt of the requisite approval of the Issuer's shareholders and the fulfillment of other customary closing conditions. The Domestication The Business Combination Agreement provides, among other things, that at least one business day prior to the closing of the transactions contemplated by the Business Combination Agreement (the "Closing" and the date upon which the Closing actually …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-07-28; the filing has the rest

Timeline

Swipe the table sideways to see every column.

Tools for this story

Each opens in a new tab, filled in for Research Alliance Corporation III. With no account yet, you sign up free and land on the result.

• Get an alert when Research Alliance Corporation III is mentioned again
• Find former Research Alliance Corporation III employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes